The India CPAP market is projected to reach USD 352.3 million in the year 2025 and is expected to total USD 649.0 million by the end of 2035, growing at a compound annual growth rate (CAGR) of 6.3% over the forecast years from 2025 to 2035.
| Attributes | Values |
|---|---|
| Estimated India Industry Size 2025 | USD 352.3 million |
| Projected India Value 2035 | USD 649.0 million |
| Value-based CAGR from 2025 to 2035 | 6.3% |
The Indian market for CPAP machines is on the rise due to growing patients coming forward with sleep apnea and breathing disorders. Multinational companies, such as ResMed, Philips Respironics, and Fisher & Paykel Healthcare, launch new technologies in the Indian market.
This therefore opens up avenues so that people can have the opportunity to see and access advanced CPAP machines. This allows people to access advanced CPAP machines. Supportive government policies and favorable reimbursement policies improve treatment access. Setting up more health and sleep centers in the country increases the chances of diagnosis rates and the acceptance of CPAP therapy.
Explore FMI!
Book a free demo
The table below offers a detailed comparative assessment of the changes in the compound annual growth rate (CAGR) over six months for the base year (2023) and the current year (2024) specifically for the India continuous positive airway pressure (CPAP) market.
This semiannual analysis highlights all the critical shifts of market dynamics as well as details the revenue realization pattern, thus more precisely providing to the stakeholders insight into the trajectory of growth within a year. In other words, H1 contains January to June, and the other half H2 contains July to December.
-market-actual-vs-estimated-cagr.png "India Continuous Positive Airway Pressure (cpap) Market Actual Vs Estimated Cagr")
H1 signifies period from January to June, H2 Signifies period from July to December
India market is expected to grow in the CPAP sector at a CAGR of 6.5% in H1 of 2023, and by second half, it should be greater than 6.9%. This is expected to decline a bit at 6.3% in H1 of 2024. The same, however, should be up by H2 to 7.0%. This would be a drop of 19 basis points from the first half of 2023 to the first half of 2024 and was higher by 7 basis points in the second half of 2024 compared with the second half of 2023.
These are the dynamic and fast-changing India continuous positive airway pressure (CPAP) market figures that are influenced significantly by regulations, consumer trends, and improvements in continuous positive airway pressure (CPAP). The semestral breakup is crucial for businesses charting their strategies by taking into account the growth trends and navigating the market complexities.
| Date | Development/M&A Activity & Details |
|---|---|
| 2025 | Expansion: Hamilton Medical AG places a strong emphasis on sustainability as a fundamental component of its strategies. The company not only prioritizes the delivery of sustainable solutions but also incorporates environmentally conscious practices across its operations. This approach is in harmony with the increasing global emphasis on sustainability, contributing to corporate responsibility and meeting the expectations of environmentally conscious consumers and stakeholders. |
| 2024 | Investment: BMC's strategic approach focuses on several core areas such as continuous investment in research and development to create advanced, user-friendly CPAP devices, expanding its market reach through strategic partnerships and distribution networks, offering comprehensive support services to help patients and caregivers understand and manage their conditions effectively, and undertaking regular audits and quality checks to maintain high standards of product performance. |
| 2024 | Certifications: Medical Pigeon company has received many certifications and awards, such as ISO13485:2016 certification, national high-tech enterprise, and successive "Contract-honoring and Credit-honoring Enterprise in Guangdong Province" since 199. |
Growing Awareness and Diagnosis of Sleep Disorders and Expansion of Home Healthcare and Telemedicine
Public health campaigns, medical education, and diagnostic improvements in hospitals and sleep centers have hastened early detection and treatment, thereby driving the demand for CPAP equipment.
With home health care solutions and telemedicine now on the rise, especially after the COVID-19 pandemic, more patients are opting for home-based treatments. The trend of remote care and monitoring ensures that CPAP usage can easily be incorporated into a home healthcare regimen for prolonged management of sleep apnea.
% share of Individual categories by Product Type and End User in 2025
-market-total-vs-top-product-.png "India Continuous Positive Airway Pressure (cpap) Market Total Vs Top Product")
PAP therapy, which comprises CPAP, BiPAP, and APAP treatments, has emerged as the mainstream treatment for sleep disorders and other respiratory conditions. The main drivers of this rising demand are an increasing problem of sleep disorders, growing rates of obesity, and growing awareness of undiagnosed sleep apnea.
Another factor is the expansion of insurance coverage and improved reimbursement policies that have made PAP treatments accessible to patients as well as the healthcare providers involved.
Hospitals most prominently present PAP devices, as most of the related diagnosis and care are provided in hospitals. Most often, people begin with a prescription for CPAP or BiPAP after undergoing a sleep study at a hospital sleep center, where these treatments are initiated along with a holistic treatment plan for sleep apnea and related conditions.
The market for CPAP in India is growing because of the increase in sleep apnea and other respiratory disorders, awareness among people about sleep health, and a growing demand for home healthcare solutions. Due to the increasing requirements for CPAP devices, the market is moderately concentrated with international and local players competing to meet the growing demand.
ResMed, Philips Respironics, and Fisher & Paykel Healthcare are the leading global brands, which have a huge market share in India. This is primarily because of the innovative technology they bring along with products and the long-standing reputation.
These companies offer CPAP, BiPAP, and APAP devices with various features such as automatic pressure adjustments, quiet operation, and remote monitoring capabilities. This has led them to become first choices for health care providers as well as patients.
At the same time, local manufacturers are slowly and steadily taking the ground with more cost-effective solutions suited to the Indian market, which is highly sensitive to price. The local companies target more affordable options that do not compromise on quality, hence allowing a wider reach of CPAP therapy among the population.
2025 Market share of India Continuous Positive Airway Pressure (CPAP) suppliers
-market-revenue-share-by-compony-2025.png "India Continuous Positive Airway Pressure (cpap) Market Revenue Share By Compony 2025")
Note: above chart is indicative in nature
By 2025, the India continuous positive airway pressure (CPAP) market is expected to grow at a CAGR of 6.3%.
By 2035, the sales value of the India continuous positive airway pressure (CPAP) industry is expected to reach India is 649.0 million.
The key drivers fueling the growth of the India continuous positive airway pressure (CPAP) market include the increasing incidence of chronic respiratory disorders and the growing obesity rates.
Prominent players in the India continuous positive airway pressure (CPAP) manufacturing include ResMed, Fisher & Paykel Healthcare, Draegerwerk AG & Co. KGaA, Medtronics, ReactHealth (3B Medical, Inc.), DeVilbiss Healthcare, Armstrong Medical, BMC Medical Co. Ltd, Hamilton Medical AG, Hebei Topson Medical Technology Co., Ltd., Nanjing Superstar Medical Equipment, SS TECHNOMED, Inspiration Healthcare(Viomedex Limited), Pigeon Medical and Others. These companies are noted for their innovation, extensive product portfolios, and strategic market positioning.
In terms of product, the industry is divided into PAP Devices (CPAP, BIPAP, and Auto CPAP), Humidifier, Masks (Full Face Masks, Nasal Masks, and Nasal Pillow Masks) and Accessories.
In terms of patient type, the industry is segregated into infants, premature, adults.
In terms of indication, the industry is segregated into chronic respiratory failure, respiratory distress syndrome (RDS), sleep apnea disorders, hypoxemia and hypoxia, among other indications.
In terms of end user, the industry is divided into hospitals, home care settings, clinics, intensive care units and sleep disorder centers.
Digital Scale Market Analysis by Product, Age Group, Modality, End User, and Region 2025 to 2035
The Graft Versus Host Disease (GvHD) Treatment Market is segmented by Monoclonal antibodies, mTOR inhibitors, Tyrosine kinase inhibitors and Thalidomide from 2025 to 2035
The Liquid Biopsy Market Is Segmented by Biomarker Type, Sample Type & End User from 2025 to 2035
The Positron Emission Tomography (PET) Scanners Market is segmented by Full-ring PET Scanner and Partial-ring PET Scanner from 2025 to 2035
The onychomycosis treatment market is segmented by treatment, disease indication, age group, gender and distribution channel from 2025 to 2035
The Breast Cancer Drug Market is segmented by Drug Class, and Distribution Channel from 2025 to 2035
India Continuous Positive Airway Pressure (CPAP) Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
